Cargando…
A systematic review of dydrogesterone for the treatment of threatened miscarriage
The objective of this systematic review was to assess whether the orally acting progestagen, dydrogesterone lowers the incidence of miscarriage in women with threatened miscarriage. A computerized search was performed in Medline, Embase, and Ovid Medline for original reports with the product name ‘D...
Autor principal: | Carp, Howard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Informa Healthcare
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3518297/ https://www.ncbi.nlm.nih.gov/pubmed/22794306 http://dx.doi.org/10.3109/09513590.2012.702875 |
Ejemplares similares
-
Efficacy and safety of Gushen Antai Pills combined with dydrogesterone in the treatment of threatened miscarriage: a systematic review and meta-analysis
por: Chen, Kai, et al.
Publicado: (2023) -
The effects of dydrogesterone treatment on first-trimester aneuploidy screening markers and nuchal translucency in women with threatened miscarriage
por: Yıldız, Elif, et al.
Publicado: (2023) -
National register data are of value in studies on miscarriage—Validation of the healthcare register data in Finland
por: Helle, Nea, et al.
Publicado: (2022) -
Biomarkers at 6 weeks' gestation in the prediction of early miscarriage in pregnancy following assisted reproductive technology
por: Guo, Jun, et al.
Publicado: (2023) -
Cervical and Vaginal Microbiomes in Early Miscarriages and Ongoing Pregnancy with and without Dydrogesterone Usage
por: Gryaznova, Mariya, et al.
Publicado: (2023)